![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
News
China’s Experimental COVID-19 Vaccine Appears Safe In Early Trials Study
COVID-19 Vaccine: In a Phase 1 trial of 191 healthy participants aged between 18 and 59, vaccination with the group's experimental shot showed no...
News
Second UK Covid-19 vaccine manufacturing site gets MHRA approval
The second of two GMP manufacturing sites for the UK’s specialist vaccines manufacturing equipment has been approved by the Medicines & Healthcare products Regulatory...
News
Zydus Cadila Covid vaccine likely to be ready by March 2021
Phase-2 trials of Zydus Cadila's indigenous vaccine ZyCoV-D is moving in the right direction and the data will be available by the end of...
Drug Research
iBio Enters into Agreement with Safi Biosolutions to Develop Growth Factors and Cytokines Using the FastPharming System
iBio, Inc., a biotech innovator and biologics contract manufacturing organization, announced that it has entered into a Master Services Agreement (“MSA”) with Boston-based Safi...
Clinical Trials
Kodiak begins three phase 3 studies of anti-VEGF antibody biopolymer conjugate, KSI-301 to treat DME and macular edema due to retinal vein occlusion
Kodiak Sciences Inc., a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, announced that the first...
News
Blue Dart strengthens temperature controlled logistics solution to fight against COVID-19
Blue Dart, India’s leading express logistics service provider and part of the Deutsche Post DHL Group (DPDHL) with its commitment to help improve the...
News
Samsung Bioepis and Biogen Announce EMA Filing Acceptance of SB11, a Proposed Biosimilar Referencing Lucentis
Samsung Bioepis Co., Ltd. and Biogen Inc. announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorisation Application for SB11,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read